表紙
市場調查報告書
商品編碼
1034619

血管閉合設備的全球市場:產品,終端用戶,各地區 -2026年為止的預測 -COVID-19的累積性的影響

Vascular Closure Device Market Research Report by Product, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日期: | 出版商: 360iResearch LLP | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球血管閉合設備的市場規模在2020年估算為12億9,879萬美元。2021年13億8,945萬美金,今後預計將以7.31%的年複合成長率擴大,到2026年將達到19億8,420萬美元。

本報告提供全球血管閉合設備市場的相關調查,提供市場機會和課題,促進及阻礙因素,COVID-19的影響,產品·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和範圍
  • 調查涵蓋年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 前提條件
  • 相關利益者

第2章 調查手法

第3章 摘要整理

第4章 市場概要

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • COVID-19累積的影響

第6章 各產品:血管閉合設備市場

  • 主動式合攏器
    • 別針型
    • 縫合型
  • 外部止血設備
  • 被動式合攏器
    • 膠原蛋白塞
    • 壓縮支援設備
    • 密封膠/凝膠為主

第7章 各終端用戶:血管閉合設備市場

  • 急性期醫療設施
  • 診所
  • 醫院

第8章 南北美洲的血管閉合設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區的血管閉合設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國

第10章 歐洲,中東·非洲的血管閉合設備市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
  • 市場排行榜分析
  • 各主要企業市場佔有率分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獲獎,獎勵,擴大

第12章 企業的實用性簡介

  • Abbott Vascular
  • B. Braun
  • Biotronik GMBH & CO.KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc
  • Cardinal Health
  • Cardiva Medical Inc.
  • COOK
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Morris Innovative, Inc.
  • Semler Technologies Inc.
  • St. Jude Medical
  • Teleflex Incorporated
  • Tricol Biomedical, Inc.
  • TZ Medical, Inc
  • Vasorum Ltd.
  • W. L. Gore & Associates

第13章 附錄

  • 討論指南
  • 許可證和價格
目錄
Product Code: MRR-ED54C46E8A94

The Global Vascular Closure Device Market size was estimated at USD 1,298.79 million in 2020 and expected to reach USD 1,389.45 million in 2021, at a CAGR 7.31% to reach USD 1,984.20 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Vascular Closure Device to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Product , the market was studied across Active Approximators, External hemostatic devices, and Passive Approximators. The Active Approximators is further studied across Clip-based devices and Suture-based devices. The Passive Approximators is further studied across Collagen plugs, Compression-Assist devices, and Sealant- or Gel-based devices.
  • Based on End-User, the market was studied across Acute Care Facilities, Clinics, and Hospitals.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vascular Closure Device Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vascular Closure Device Market, including Abbott Vascular, B. Braun, Biotronik GMBH & CO.KG, Boston Scientific Corporation, C. R. Bard, Inc, Cardinal Health, Cardiva Medical Inc., COOK, Medtronic PLC, Merit Medical Systems, Inc., Morris Innovative, Inc., Semler Technologies Inc., St. Jude Medical, Teleflex Incorporated, Tricol Biomedical, Inc., TZ Medical, Inc, Vasorum Ltd., and W. L. Gore & Associates.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Vascular Closure Device Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vascular Closure Device Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vascular Closure Device Market?
  • 4. What is the competitive strategic window for opportunities in the Global Vascular Closure Device Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Vascular Closure Device Market?
  • 6. What is the market share of the leading vendors in the Global Vascular Closure Device Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Vascular Closure Device Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of cardiovascular diseases globally
      • 5.1.1.2. Rising popularity of femoral artery cardiac catheterization
      • 5.1.1.3. Growing success rate of VCDs and short hemostasis time
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of the procedure and patients' predilection for interventional procedures using radial artery access
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging concentration on large-bore vascular closure devices
      • 5.1.3.2. Development of VCDs to tackle complications such as patient discomfort and prolonged bed rest
    • 5.1.4. Challenges
      • 5.1.4.1. Probability of product recalls and failure coupled with risks related to VCDs
  • 5.2. Cumulative Impact of COVID-19

6. Vascular Closure Device Market, by Product

  • 6.1. Introduction
  • 6.2. Active Approximators
    • 6.2.1. Clip-based devices
    • 6.2.2. Suture-based devices
  • 6.3. External hemostatic devices
  • 6.4. Passive Approximators
    • 6.4.1. Collagen plugs
    • 6.4.2. Compression-Assist devices
    • 6.4.3. Sealant- or Gel-based devices

7. Vascular Closure Device Market, by End-User

  • 7.1. Introduction
  • 7.2. Acute Care Facilities
  • 7.3. Clinics
  • 7.4. Hospitals

8. Americas Vascular Closure Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Vascular Closure Device Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand

10. Europe, Middle East & Africa Vascular Closure Device Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Vascular
  • 12.2. B. Braun
  • 12.3. Biotronik GMBH & CO.KG
  • 12.4. Boston Scientific Corporation
  • 12.5. C. R. Bard, Inc
  • 12.6. Cardinal Health
  • 12.7. Cardiva Medical Inc.
  • 12.8. COOK
  • 12.9. Medtronic PLC
  • 12.10. Merit Medical Systems, Inc.
  • 12.11. Morris Innovative, Inc.
  • 12.12. Semler Technologies Inc.
  • 12.13. St. Jude Medical
  • 12.14. Teleflex Incorporated
  • 12.15. Tricol Biomedical, Inc.
  • 12.16. TZ Medical, Inc
  • 12.17. Vasorum Ltd.
  • 12.18. W. L. Gore & Associates

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL VASCULAR CLOSURE DEVICE MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL VASCULAR CLOSURE DEVICE MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT , 2020 VS 2026 (%)
  • FIGURE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT , 2020 VS 2026 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT , 2026
  • FIGURE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2026 (USD MILLION)
  • FIGURE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP-BASED DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP-BASED DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE-BASED DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE-BASED DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL HEMOSTATIC DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL HEMOSTATIC DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUGS, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUGS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COMPRESSION-ASSIST DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COMPRESSION-ASSIST DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT- OR GEL-BASED DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT- OR GEL-BASED DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 23. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2026
  • FIGURE 25. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACUTE CARE FACILITIES, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACUTE CARE FACILITIES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 32. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 33. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 34. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 35. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 36. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 37. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 38. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 39. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 40. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 41. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 42. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 43. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 44. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 45. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 46. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 47. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 48. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 49. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 50. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 51. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 52. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 53. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 54. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 55. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 56. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 57. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 58. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 59. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 60. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 61. GLOBAL VASCULAR CLOSURE DEVICE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 62. GLOBAL VASCULAR CLOSURE DEVICE MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 63. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VASCULAR CLOSURE DEVICE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL VASCULAR CLOSURE DEVICE MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT , 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP-BASED DEVICES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE-BASED DEVICES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL HEMOSTATIC DEVICES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUGS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COMPRESSION-ASSIST DEVICES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT- OR GEL-BASED DEVICES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACUTE CARE FACILITIES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 16. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 17. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 18. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 19. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 20. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 21. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 22. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 23. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 24. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 25. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 26. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 27. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 28. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 29. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 30. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 31. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 32. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 33. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 34. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 35. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 36. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 37. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 38. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 39. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 42. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 43. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 44. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 45. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 46. GLOBAL VASCULAR CLOSURE DEVICE MARKET: SCORES
  • TABLE 47. GLOBAL VASCULAR CLOSURE DEVICE MARKET: BUSINESS STRATEGY
  • TABLE 48. GLOBAL VASCULAR CLOSURE DEVICE MARKET: PRODUCT SATISFACTION
  • TABLE 49. GLOBAL VASCULAR CLOSURE DEVICE MARKET: RANKING
  • TABLE 50. GLOBAL VASCULAR CLOSURE DEVICE MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 51. GLOBAL VASCULAR CLOSURE DEVICE MARKET: MERGER & ACQUISITION
  • TABLE 52. GLOBAL VASCULAR CLOSURE DEVICE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 53. GLOBAL VASCULAR CLOSURE DEVICE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 54. GLOBAL VASCULAR CLOSURE DEVICE MARKET: INVESTMENT & FUNDING
  • TABLE 55. GLOBAL VASCULAR CLOSURE DEVICE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 56. GLOBAL VASCULAR CLOSURE DEVICE MARKET: LICENSE & PRICING